Dasatinib
NDC 70377-087, dasatinib, tablet, film coated, from Biocon Pharma Inc..
- Product NDC
- 70377-087
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217217
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB100 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-087-11 | 70377008711 | 30 TABLET, FILM COATED in 1 BOTTLE (70377-087-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/76e1833c-e105-5a3d-0f01-1330d8cc7ae1NADAC price for package 70377008711
GET /v1/drugs/nadac/70377008711
Use it
Look up 70377-087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.